Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. LFCR
LFCR logo

LFCR Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Lifecore Biomedical Inc (LFCR) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
5.020
1 Day change
1.01%
52 Week Range
8.980
Analysis Updated At
2026/05/29
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

LFCR is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock shows some improving momentum and constructive options sentiment, but there is no AI Stock Picker or SwingMax buy signal today, no recent news catalyst, and analyst views remain mixed despite a more optimistic long-term turnaround narrative. My direct view is to hold off for now rather than buy immediately.

Technical Analysis

LFCR is trading pre-market at 4.97, just below the key resistance level at 5.038 and above the pivot at 4.683. MACD is positive and expanding, which supports short-term bullish momentum, but RSI at 66.12 is nearing overbought territory and the moving averages are still converging, suggesting the trend is not yet fully confirmed. The pattern-based trend data also points to weakness over the next week, with a 70% chance of -4.36%, which argues against an immediate long-term entry at current levels.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment is mildly bullish. The put-call open interest ratio of 0.48 suggests more call positioning than puts, which leans positive. However, option volume is extremely thin with only 1 contract traded today and call volume at 0, so the signal is not very strong. Implied volatility at 76.46 is elevated, showing the market expects meaningful movement, but the lack of meaningful flow reduces confidence in the options signal.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
6
Buy
6

Positive Catalysts

  • ["Barrington raised its price target to $6 from $5.50 and reiterated Outperform on 2026-04-29.", "Barrington said Lifecore is now in an execution phase, which supports the turnaround thesis.", "Options positioning leans bullish with a 0.48 put-call open interest ratio.", "MACD is positive and expanding, indicating improving near-term momentum."]

Neutral/Negative Catalysts

  • ["No news in the recent week, so there is no fresh event-driven catalyst.", "Stephens lowered its price target to $5 from $8.50 on 2026-03-17 after FY26 guidance disappointed.", "The next-week stock pattern outlook is weak, with a 70% chance of -4.36%.", "No AI Stock Picker signal today and no recent SwingMax entry signal.", "Hedge fund and insider trading trends are neutral.", "No recent congress trading data is available."]

Financial Performance

Latest quarter financial data was not available due to a snapshot error, so there is no reliable quarter-by-quarter revenue or earnings breakdown to assess. Based on analyst commentary, the company did report a solid Q4, but FY26 guidance came in below expectations and the timing of commercial ramps was pushed outward. That suggests the latest reported season likely reflected progress, but not yet strong enough growth confirmation for a beginner long-term buy.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst sentiment is mixed but improving on the bullish side. Barrington upgraded LFCR to Outperform on 2026-03-17 and later raised its price target to $6 on 2026-04-29, signaling growing confidence in the turnaround. In contrast, Stephens cut its target to $5 from $8.50 and kept an Equal Weight rating after softer FY26 guidance. Wall Street is split: the pro case is long-term execution and value creation, while the cautious case is that growth ramps are delayed and the stock still needs proof of delivery.

Wall Street analysts forecast LFCR stock price to rise
Analyst Rating
0
Wall Street analysts forecast LFCR stock price to rise
Buy
Hold
Sell
0
Current: 4.970
sliders
Low
0
Averages
0
High
0
0
Current: 4.970
sliders
Low
0
Averages
0
High
0
Barrington
Barrington
Outperform
maintain
$6
AI Analysis
2026-04-29
Reason
Barrington
Barrington
Price Target
$6
AI Analysis
2026-04-29
maintain
Outperform
Reason
Barrington raised the firm's price target on Lifecore to $6 from $5.50 and keeps an Outperform rating on the shares after meeting with management. The company "repeatedly suggested last week that it has now largely acquired the people resources that it needs to execute its strategic vision," the analyst tells investors in a research note. the firm says Lifecore's turnaround story is now at an execution phase.
Barrington
Market Perform -> Outperform
upgrade
$5.50
2026-03-17
Reason
Barrington
Price Target
$5.50
2026-03-17
upgrade
Market Perform -> Outperform
Reason
Barrington upgraded Lifecore to Outperform from Market Perform with a $5.50 price target. While the firm now thinks 2028, rather than 2027, will represent "the breakout year for Lifecore," it expects further long-term value creation via additional programs, including site transfer wins, in the meantime.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for LFCR
Unlock Now

People Also Watch